DarioHealth Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2026 Annual Meeting of Stockholders held by DarioHealth Corp. on January 29, 2026. The filing details the voting outcomes for seven proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Stockholders approved all seven proposals presented at the meeting. Key outcomes include:
- Director Elections: All seven nominees (Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Yoav Shaked, Lawrence Leisure, and Adam K. Stern) were elected. Notably, Lawrence Leisure received the highest number of "Against" votes (4,166,444) among the directors, while others received significantly fewer dissenting votes.
- Auditor Ratification: Kesselman & Kesselman (PricewaterhouseCoopers International Limited) was ratified as the independent auditor for the fiscal year ending December 31, 2026.
- Preferred Stock Conversion: Stockholders ratified the conversion of 25,605 shares of Series D, D-1, D-2, and D-3 Preferred Stock into approximately 1.7 million shares of common stock, along with related dividend and lock-up share issuances.
- Twill Acquisition: The issuance of common stock upon the exercise of warrants and RSUs related to the acquisition of Twill Inc. was ratified.
- Equity Plan Amendment: The 2020 Equity Incentive Plan was amended to increase authorized shares by 500,000.
- Executive Compensation: A non-binding advisory resolution regarding executive compensation was approved.
- Charter Amendment: The Certificate of Incorporation was amended to grant the board of directors the right to amend the company's bylaws.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the standard disclosure of voting results.
Investor Verification Checklist
- Verify the specific terms of the Twill Inc. acquisition warrants and RSUs to understand potential future dilution.
- Review the details of the Series D Preferred Stock conversion to assess the impact on the total share count and capitalization.
- Monitor the implementation of the 500,000 share increase in the Equity Incentive Plan for future employee compensation costs.
- Confirm the implications of the charter amendment granting the board authority to amend bylaws without further shareholder approval.